| Name | Title | Contact Details |
|---|
At KayOne Consulting, we help clients on key strategic issues, leveraging our deep industry expertise. We specialize in CFO services, transaction advisory and strategic consulting. Using our inputs backed by research, and analytical rigor, we are able to help clients make informed decisions more quickly, and solve their toughest problems.
FifthWall Solutions is a top-rated cyber insurance partner that works with 1,500+ MSPs and their clients, accessing 45+ carriers to offer the best rates and coverage options. FifthWall also educates and equips MSPs to navigate the cyber insurance process for their clients and leverage their stack along the way. Interested in partnering with FifthWall Solutions? Message us at info@fifthwallsolutions.com or call us at 844.719.0981.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
JELD-WEN is a leading global designer, manufacturer and distributor of high-performance interior and exterior doors, windows, and related building products serving the new construction and repair and remodeling sectors. Headquartered in Charlotte, N.C., the company operates facilities in 16 countries in North America and Europe and employs approximately 18,000 people. Since 1960, the JELD-WEN team has been committed to making quality products that create safe and sustainable environments for customers, associates and local communities. The JELD-WEN family of brands includes JELD-WEN® worldwide, LaCantina™ and VPI™ in North America, and Swedoor® and DANA® in Europe. For more information about JELD-WEN or to join our team, visit https://www.corporate.jeld-wen.com/.